微创前路或前外侧入路与常规后路或直接外侧入路的植入物生存率:基于挪威关节置换登记处2008至2013年21860例全髋关节置换术的分析
基于挪威关节置换登记处2008至2013年21860例非骨水泥柄全髋关节置换术,比较微创前路、微创前外侧路与常规后路、直接外侧路的翻修率及翻修风险。中位随访4.3年,各入路2年及5年生存率及任何原因翻修RR无显著差异;微创前路及前外侧路与后路感染翻修RR均低于直接外侧路,后路脱位翻修RR高于直接外侧路。
要点
- 微创前路及前外侧路与常规后路及直接外侧路相比,翻修率及任何原因翻修风险未增加。
- 感染翻修RR:微创前路及前外侧路0.53(95%CI 0.36-0.80,p=0.002),后路0.57(95%CI 0.40-0.80,p=0.001),均低于直接外侧路。
- 脱位翻修RR:后路2.1(95%CI 1.5-3.1,p<0.001)高于直接外侧路;微创前路及前外侧路0.71(95%CI 0.40-1.3,p=0.25)与直接外侧路无显著差异。
核心结论
- 微创前路及前外侧路的翻修率及翻修风险与常规后路及直接外侧路相比未增加。
研究设计与样本
- 基于挪威关节置换登记处的队列研究,纳入2008至2013年21860例非骨水泥柄全髋关节置换术。
- 微创前路2017例,微创前外侧路2087例,后路5961例,直接外侧路11795例;随访截至2015年12月31日,中位随访4.3年。
- 采用Kaplan-Meier法计算2年及5年生存率,Cox回归计算相对风险(RR),校正年龄、性别、主要诊断、美国麻醉医师协会(ASA)分级、股骨头尺寸、髋臼杯固定、关节面类型及手术时长,设6个基于原因的翻修终点。
主要发现
- 各手术入路间2年及5年生存率及任何原因翻修RR无显著差异。
- 感染翻修RR:微创前路及前外侧路0.53(95%CI 0.36-0.80,p=0.002),后路0.57(95%CI 0.40-0.80,p=0.001),均低于直接外侧路。
- 脱位翻修RR:后路2.1(95%CI 1.5-3.1,p<0.001)高于直接外侧路;微创前路及前外侧路0.71(95%CI 0.40-1.3,p=0.25)与直接外侧路无显著差异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Since 2008, there has been an increase in the use of minimally invasive surgery (MIS) through an anterior or anterolateral approach for total hip arthroplasty (THA) in Norway. We compared the MIS approaches with the conventional posterior and direct lateral approaches in terms of revision rates and risk of revision. METHODS: On the basis of data in the Norwegian Arthroplasty Register, 21,860 THAs with an uncemented stem, performed between 2008 and 2013, were identified and included in the cohort. Of these THAs, 2,017 were done through an MIS anterior approach; 2,087, through an MIS anterolateral approach; 5,961, through a posterior approach; and 11,795, through a direct lateral approach. Follow-up ended on December 31, 2015. Two and 5-year survival rates were calculated using Kaplan-Meier survival analysis. Relative risk (RR) was calculated using Cox regression analysis, with adjustment for age, sex, primary diagnosis, American Society of Anesthesiologists (ASA) grade, femoral head size, cup fixation, type of articulation, and duration of surgery and using 6 revision end points based on cause: any cause, infection, dislocation, femoral fracture, aseptic loosening, and other/unknown cause. The median duration of follow-up was 4.3 years. RESULTS: There were no significant differences among the surgical approaches with regard to the 2 and 5-year survival rates or RR of revision due to any cause. The RR of revision due to infection was 0.53 (95% confidence interval [CI] = 0.36 to 0.80, p = 0.002) for the MIS anterior and anterolateral approaches and 0.57 (95% CI = 0.40 to 0.80, p = 0.001) for the posterior approach compared with the direct lateral approach. The RR of revision due to dislocation was 2.1 (95% CI = 1.5 to 3.1, p < 0.001) for the posterior approach compared with the direct lateral approach but no significant difference in risk was found when the MIS anterior and anterolateral approaches were compared with the direct lateral approach (RR = 0.71, 95% CI = 0.40 to 1.3, p = 0.25). CONCLUSIONS: The revision rates and risk of revision associated with the MIS anterior and anterolateral approaches were not increased compared with those of the conventional posterior and direct lateral approaches. LEVEL OF EVIDENCE: Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.
引用
- Mjaaland KE, Svenningsen S, Fenstad AM, et al. Implant Survival After Minimally Invasive Anterior or Anterolateral Vs. Conventional Posterior or Direct Lateral Approach: An Analysis of 21,860 Total Hip Arthroplasties from the Norwegian Arthroplasty Register (2008 to 2013). J Bone Joint Surg Am. 2017. PMID: 28509824. doi:10.2106/JBJS.16.00494
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。